Allison Schwartz - 01 Sep 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Director
Signature
/s/ Allison Schwartz
Issuer symbol
BIO
Transactions as of
01 Sep 2025
Net transactions value
-$16,383
Form type
4
Filing time
03 Sep 2025, 18:03:55 UTC
Previous filing
10 Sep 2024
Next filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Allison Schwartz Director C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Allison Schwartz 02 Sep 2025 0001924980

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +147 +11% $0.000000 1,452 01 Sep 2025 Direct F1
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $16,383 -55 -3.8% $297.88 1,397 01 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -31 -100% $0.000000 0 01 Sep 2025 Bio-Rad A Common Stock 31 $0.000000 Direct F2, F3
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -42 -50% $0.000000 42 01 Sep 2025 Bio-Rad A Common Stock 42 $0.000000 Direct F2, F4
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -74 -33% $0.000000 150 01 Sep 2025 Bio-Rad A Common Stock 74 $0.000000 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4 On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5 On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.